Advertisement
Journal Home
Search for

9 Periodical Search Results

You searched for "lenograstim" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-9  of 9 results  

Results Page:  [1]

display abstract citation download email a colleague
Display:

  1. A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma
    A.-M. Seymour, E. de Campos, N. Thatcher, J. De Greve, D. Cunningham, A. Howell, E. Tueni, D.G. Bron, W.P. Steward, W.E. Berdel, A. Knuth, J. Lorenz, A.R. Timothy, A. Yver, M.A. Richards
    European Journal of Cancer
    December 1995 (Vol. 31, Issue 13, Pages 2157-2163)
    Abstract | Abstract + References | Full-Text PDF (755 KB)

  1. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
    M.S. Aapro, D.A. Cameron, R. Pettengell, J. Bohlius, J. Crawford, M. Ellis, N. Kearney, G.H. Lyman, V.C. Tjan-Heijnen, J. Walewski, D.C. Weber, C. Zielinski, European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party
    European Journal of Cancer
    October 2006 (Vol. 42, Issue 15, Pages 2433-2453)
    Abstract | Full Text | Full-Text PDF (309 KB)

  1. Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumours
    M Louwerens, C Smorenburg, A Sparreboom, W.J Loos, J Verweij, R de Wit
    European Journal of Cancer
    March 2002 (Vol. 38, Issue 4, Pages 497-504)
    Abstract | Full Text | Full-Text PDF (125 KB)

  1. Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patients
    W.W. ten Bokkel Huinink, V. Lustig, R. Dubbelman, A. Hiemstra, S. Rodenhuis
    European Journal of Cancer
    August 1997 (Vol. 33Supplement 7, Pages S23-S25)
    Abstract | Abstract + References | Full-Text PDF (339 KB)

  1. The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients , 15 January 2008
    Christoph C. Zielinski, Ahmad Awada, David A. Cameron, Tanja Cufer, Miguel Martin, Matti Aapro
    European Journal of Cancer
    February 2008 (Vol. 44, Issue 3, Pages 353-365)
    Abstract | Full Text | Full-Text PDF (474 KB)

  1. Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study , 08 August 2008
    Gerasimos Aravantinos, George Fountzilas, Aristotelis Bamias, Irene Grimani, Spyridon Rizos, Haralabos P. Kalofonos, Dimosthenis V. Skarlos, Theofanis Economopoulos, Paris A. Kosmidis, George P. Stathopoulos, Evangelos Briasoulis, Dimitrios Pectasides, Epaminondas Samantas, Eleni Timotheadou, Christos Papadimitriou, Alexandros Papanikolaou, Adimchi Onyenadum, Pavlos Papakostas, Dimitrios Bafaloukos, Meletios A. Dimopoulos
    European Journal of Cancer
    October 2008 (Vol. 44, Issue 15, Pages 2169-2177)
    Abstract | Full Text | Full-Text PDF (191 KB)

  1. Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis , 25 December 2008
    G. von Minckwitz, M. Schwenkglenks, T. Skacel, G.H. Lyman, A. Lopez Pousa, P. Bacon, V. Easton, M.S. Aapro
    European Journal of Cancer
    March 2009 (Vol. 45, Issue 4, Pages 608-617)
    Abstract | Full Text | Full-Text PDF (225 KB)

  1. The EORTC Soft Tissue and Bone Sarcoma Group
    E Donato Di Paola, O.S Nielsen, on behalf of the EORTC Soft Tissue and Bone Sarcoma Group
    European Journal of Cancer
    March 2002 (Vol. 38Supplement 4, Pages 138-141)
    Abstract | Full Text | Full-Text PDF (85 KB)

  1. An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma
    J.M Michon, O Hartmann, E Bouffet, V Meresse, C Coze, H Rubie, P Bordigoni, E Cattiaux, N Ward, J.-L Bernard, J Lemerle, J.-M Zucker, T Philip
    European Journal of Cancer
    June 1998 (Vol. 34, Issue 7, Pages 1063-1069)
    Abstract | Full Text | Full-Text PDF (148 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-9  of 9 results  

Results Page:  [1]

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement